AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Est. Return
13.43%
1 Year Est. Return
+13.43%
AUM
$17.3B
AUM Growth
+$91.5M
(+0.53%)
Holding
1,066
Top Buys
| 1 | +$100M | |
| 2 | +$99.4M | |
| 3 | +$41.5M | |
| 4 |
Western Midstream Partners
WES
|
+$32.9M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$28.1M |
Top Sells
| 1 | +$32.7M | |
| 2 | +$20.4M | |
| 3 | +$19.4M | |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$17M |
| 5 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$13.4M |
Sector Composition
| 1 | Energy | 68.28% |
| 2 | Technology | 4.29% |
| 3 | Financials | 3.4% |
| 4 | Consumer Discretionary | 2.95% |
| 5 | Materials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Alector
ALEC
$323M
| – | – |
-74,933
|
|
||
1052
Amylyx Pharmaceuticals
AMLX
$1.68B
| – | – |
-67,597
|
|
||
1053
Atlas Lithium Corp
ATLX
$143M
| – | – |
-10,779
|
|
||
1054
Aura Biosciences
AURA
$383M
| – | – |
-37,156
|
|
||
1055
Grupo Cibest SA
CIB
$13.1B
| – | – |
-11,894
|
|
||
|
CRGX
1056
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-33,158
|
|
||
1057
Darling Ingredients
DAR
$4.99B
| – | – |
-136,520
|
|
||
|
DEA
1058
Easterly Government Properties
DEA
$979M
| – | – |
-10,184
|
|
||
1059
Eledon Pharmaceuticals
ELDN
$164M
| – | – |
-44,436
|
|
||
1060
Enanta Pharmaceuticals
ENTA
$316M
| – | – |
-16,257
|
|
||
1061
4D Molecular Therapeutics
FDMT
$465M
| – | – |
-32,811
|
|
||
|
1062
Schwab Fundamental US Small Company Index ETF
FNDA
$9.14B
| – | – |
-619,058
|
|
||
1063
Schwab Fundamental US Large Company Index ETF
FNDX
$20.7B
| – | – |
-1,385,646
|
|
||
1064
Ironwood Pharmaceuticals
IRWD
$262M
| – | – |
-116,860
|
|
||
|
JWN
1065
DELISTED
Nordstrom
JWN
| – | – |
-28,250
|
|
||
1066
Liquidia Corp
LQDA
$1.96B
| – | – |
-62,656
|
|